VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

NCT00171015 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

212

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: valsartan plus hydrochlorothiazide

Sponsor

Novartis